联系我们

Email: info@gdklondon.com
Opening: 08AM - 09PM
tact.html" class="bizwheel-btn">关于我们
-->

公司资讯

首页

研修感悟

13

Apr

0

研修感悟-柯医生4

June,11th , 2019 cloudy

Revision control sheet of HFEA (Version 1.0)

Preparation for treatment 

l Centres must provide information and offer counselling for people about the implications of treatment. Centres should ensure that all patients are prepared for treatment. Preparation for treatment includes the provision of information, the discussion of the implications involved, and the offer of counselling. 

l Centres should explain the role of counselling for emotional support. Where a person chooses not to take up the offer of counselling, the implications of treatment must be discussed as part of their preparation for treatment. The discussion of implications forms part of the routine provision of information prior to consent, and the person should be given enough time to consider those implications before consenting.  

l Centres should ensure that patients have a suitable opportunity to discuss the emotional impact of those implications. Given that emotional issues may surface during the discussion of implications, a qualified counsellor is best suited to having these discussions, even in those cases where the offer of counselling has been declined. Where a qualified counsellor is not available, the PR should be able to assure themselves that the member of staff leading the discussion is sufficiently skilled, knowledgeable and experienced. 4.4 In cases involving third party donation and surrogacy arrangements, our expectation is that the discussion of implications should be delivered by a qualified counsellor. 


June,12th , 2019 cloudy

Information about the risks of treatment  

Before treatment is offered, the centre should give the woman seeking treatment and her partner, if applicable, information about: (a)   the potential immediate and longer-term risks of the treatment and any treatment add ons used, including the risks to the patient and the possibility of any children conceived having developmental and birth defects (b) the nature and potential risks of any alternative treatment options available so the patient can make an informed decision about their treatment (c)  the possibility of developing ovarian hyperstimulation syndrome (OHSS); any information provided should include the possible symptoms of OHSS, what the woman being treated should do and who to contact if experiencing symptoms of OHSS (d) the nature and potential risks (immediate and longer term) of using emerging or unproven treatments, including reference to the clinic’s experience and wider evidence base (e)  the potential risk of emotional distress associated with negative outcomes both during and after treatment. Information about success rates 

In line with the Advertising Standards Authority’s Code, the centre should ensure that the information provided on its website complies with the following guidance. This also applies to other relevant marketing communications of the centre and associated satellite and transport centres. (a)  The information should include the most recent data available from the past three years. (b)  Centres are encouraged to display live birth rate data per embryo transferred where relevant and this may be displayed alongside other success rate measures. The information should not highlight a high success rate that applies only to a small, selected group of patients. (c)  The data should show split by maternal age and, if appropriate, by treatment type. (d)  The information should provide raw numbers rather than just percentages. (e)  The website should provide the national rate and like-for-like comparisons (the same yea.


June,13th , 2019 cloudy

Use of gametes for treatment of others 

(1)  A person's gametes must not be used for the purposes of treatment services or nonmedical fertility services unless there is an effective consent by that person to their being so used and they are used in accordance with the terms of the consent. (2)  A person's gametes must not be received for use for those purposes unless there is an effective consent by that person to their being so used. (3)  This paragraph does not apply to the use of a person's gametes for the purpose of that person, or that person and another together, receiving treatment services. In vitro fertilisation and subsequent use of embryo 

(2)  A person's gametes or human cells must not be used to bring about the creation of any embryo in vitro unless there is an effective consent by that person to any embryo, the creation of which may be brought about with the use of those gametes or human cells, being used for one or more of the purposes mentioned in paragraph 2(1)(a), (b) and (c) above. (2)  An embryo the creation of which was brought about in vitro must not be received by any person unless there is an effective consent by each relevant person in relation to the embryo to the use for one or more of the purposes mentioned in paragraph 2(1)(a), (b), (ba) and (c) above of the embryo. (3)  An embryo the creation of which was brought about in vitro must not be used for any purpose unless there is an effective consent by each relevant person in relation to the embryo to the use for that purpose of the embryo and the embryo is used in accordance with those consents. … (3E)  For the purposes of sub-paragraphs (2), (3) and (3B) each of the following is a relevant person in relation to an embryo the creation of which was brought about in vitro (“embryo A”) - (a)  each person whose gametes or human cells were used to bring about the creation of embryo A, (b)  each person whose gametes or human cells were used to bring about the creation of any other embryo, the creation of which was b



June,14th , 2019 cloudy

Storage of gametes and embryos

(1)  A person's gametes must not be kept in storage unless there is an effective consent by that person to their storage and they are stored in accordance with the consent. (2)  An embryo the creation of which was brought about in vitro must not be kept in storage unless there is an effective consent, by each relevant person in relation to the embryo, to the storage of the embryo and the embryo is stored in accordance with those consents… (2C)  For the purposes of sub-paragraphs (2) and (2A) each of the following is a relevant person in relation to an embryo the creation of which was brought about in vitro (“embryo A”) - (a)  each person whose gametes or human cells were used to bring about the creation of embryo A, (b)  each person whose gametes or human cells were used to bring about the creation of any other embryo, the creation of which was brought about in vitro, which was used to bring about the creation of embryo A, and (c)  each person whose gametes or human cells were used to bring about the creation of any human admixed embryo, the creation of which was brought about in vitro, which was used to bring about the creation of embryo A. (3) An embryo taken from a woman must not be kept in storage unless there is an effective consent by her to its storage and it is stored in accordance with the consent. (4)  Sub-paragraph (1) has effect subject to paragraphs 9 and 10; and sub-paragraph (2) has effect subject to paragraphs 4A(4), 16 and 20.


June,17th , 2019 cloudy

Parenthood in cases involving assisted reproduction.

Meaning of "mother" (1)  The woman who is carrying or has carried a child as a result of the placing in her of an embryo or of sperm and eggs, and no other woman, is to be treated as the mother of the child. (2)   Subsection (1) does not apply to any child to the extent that the child is treated by virtue of adoption as not being the woman’s child. (3)  Subsection (1) applies whether the woman was in the United Kingdom or elsewhere at the time of the placing in her of the embryo or the sperm and eggs.

Meaning of "father" 35 Women married [to a man] at time of treatment (1)  If - (a)  at the time of the placing in her of the embryo or of the sperm and eggs or of her artificial insemination, W was a party to a marriage [with a man], and (b)  the creation of the embryo carried by her was not brought about with the sperm of the other party to the marriage, then, subject to section 38(2) to (4), the other party to the marriage is to be treated as the father of the child unless it is shown that he did not consent to the placing in her of the embryo or the sperm and eggs or to her artificial insemination (as the case may be). (2)  This section applies whether W was in the United Kingdom or elsewhere at the time mentioned in subsection (1)(a).


图片12.jpg


June,19th , 2019 cloudy 

It is believed that every student yearns for Cambridge university. In this great academic city, Cambridge Reproductive Center is also located in the town.It is a school that hopes to share academic knowledge with scholars from every corner of the world. Chinese students are welcome to have academic exchanges, academic visits and further studies there.